283 related articles for article (PubMed ID: 38443977)
21. Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for lung cancer.
Song W; Li Y; Yao Y; Sun S; Guan X; Wang B
BMC Cancer; 2024 Jun; 24(1):680. PubMed ID: 38834983
[TBL] [Abstract][Full Text] [Related]
22. Causal association of type 2 diabetes with amyotrophic lateral sclerosis: new evidence from Mendelian randomization using GWAS summary statistics.
Zeng P; Wang T; Zheng J; Zhou X
BMC Med; 2019 Dec; 17(1):225. PubMed ID: 31796040
[TBL] [Abstract][Full Text] [Related]
23. The Loss of TBK1 Kinase Activity in Motor Neurons or in All Cell Types Differentially Impacts ALS Disease Progression in SOD1 Mice.
Gerbino V; Kaunga E; Ye J; Canzio D; O'Keeffe S; Rudnick ND; Guarnieri P; Lutz CM; Maniatis T
Neuron; 2020 Jun; 106(5):789-805.e5. PubMed ID: 32220666
[TBL] [Abstract][Full Text] [Related]
24. Bidirectional Mendelian randomization to explore the causal relationships between Sleep traits, Parkinson's disease and Amyotrophic lateral sclerosis.
Di H; Zhu Y; Xia W; Meng X; Zhang M; Xu M; Feng J; Tian Q; He Y; Cao S; Lu Z
Sleep Med; 2022 Aug; 96():42-49. PubMed ID: 35594779
[TBL] [Abstract][Full Text] [Related]
25. ALS-associated TBK1 variant p.G175S is defective in phosphorylation of p62 and impacts TBK1-mediated signalling and TDP-43 autophagic degradation.
Foster AD; Downing P; Figredo E; Polain N; Stott A; Layfield R; Rea SL
Mol Cell Neurosci; 2020 Oct; 108():103539. PubMed ID: 32835772
[TBL] [Abstract][Full Text] [Related]
26. Neuropathological characterization of a novel TANK binding kinase (TBK1) gene loss of function mutation associated with amyotrophic lateral sclerosis.
Weinreich M; Shepheard SR; Verber N; Wyles M; Heath PR; Highley JR; Kirby J; Shaw PJ
Neuropathol Appl Neurobiol; 2020 Apr; 46(3):279-291. PubMed ID: 31498468
[TBL] [Abstract][Full Text] [Related]
27. Leukocyte telomere length and amyotrophic lateral sclerosis: a Mendelian randomization study.
Xia K; Zhang L; Zhang G; Wang Y; Huang T; Fan D
Orphanet J Rare Dis; 2021 Dec; 16(1):508. PubMed ID: 34906191
[TBL] [Abstract][Full Text] [Related]
28. Identifying novel genes for amyotrophic lateral sclerosis by integrating human brain proteomes with genome-wide association data.
Gu XJ; Su WM; Dou M; Jiang Z; Duan QQ; Wang H; Ren YL; Cao B; Wang Y; Chen YP
J Neurol; 2023 Aug; 270(8):4013-4023. PubMed ID: 37148340
[TBL] [Abstract][Full Text] [Related]
29. TBK1 variants in Chinese patients with amyotrophic lateral sclerosis: Genetic analysis and clinical features.
Zhao B; Jiang Q; Lin J; Wei Q; Li C; Hou Y; Cao B; Zhang L; Ou R; Liu K; Yang T; Xiao Y; Shang H
Eur J Neurol; 2023 Oct; 30(10):3079-3089. PubMed ID: 37422901
[TBL] [Abstract][Full Text] [Related]
30. Lipids and amyotrophic lateral sclerosis: A two-sample Mendelian randomization study.
Xia K; Klose V; Högel J; Huang T; Zhang L; Dorst J; Fan D; Ludolph AC
Eur J Neurol; 2023 Jul; 30(7):1899-1906. PubMed ID: 36999624
[TBL] [Abstract][Full Text] [Related]
31. An Updated Evolutionary and Structural Study of TBK1 Reveals Highly Conserved Motifs as Potential Pharmacological Targets in Neurodegenerative Diseases.
Papageorgiou L; Mangana E; Papakonstantinou E; Diakou I; Pierouli K; Dragoumani K; Bacopoulou F; Chrousos GP; Exarchos TP; Vlamos P; Eliopoulos E; Vlachakis D
Adv Exp Med Biol; 2023; 1423():41-57. PubMed ID: 37525032
[TBL] [Abstract][Full Text] [Related]
32. Association of the New Variant Tyr424Asp at TBK1 Gene with Amyotrophic Lateral Sclerosis and Cognitive Decline.
Piaceri I; Bessi V; Matà S; Polito C; Tedde A; Berti V; Bagnoli S; Braccia A; Del Mastio M; Pignone AM; Pupi A; Sorbi S; Nacmias B
J Alzheimers Dis; 2018; 61(1):41-46. PubMed ID: 29103041
[TBL] [Abstract][Full Text] [Related]
33. FUS mutations dominate TBK1 mutations in FUS/TBK1 double-mutant ALS/FTD pedigrees.
Brenner D; Müller K; Lattante S; Yilmaz R; Knehr A; Freischmidt A; Ludolph AC; Andersen PM; Weishaupt JH
Neurogenetics; 2022 Jan; 23(1):59-65. PubMed ID: 34518945
[TBL] [Abstract][Full Text] [Related]
34. Functional and structural consequences of TBK1 missense variants in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Gurfinkel Y; Polain N; Sonar K; Nice P; Mancera RL; Rea SL
Neurobiol Dis; 2022 Nov; 174():105859. PubMed ID: 36113750
[TBL] [Abstract][Full Text] [Related]
35. Novel TBK1 truncating mutation in a familial amyotrophic lateral sclerosis patient of Chinese origin.
Williams KL; McCann EP; Fifita JA; Zhang K; Duncan EL; Leo PJ; Marshall M; Rowe DB; Nicholson GA; Blair IP
Neurobiol Aging; 2015 Dec; 36(12):3334.e1-3334.e5. PubMed ID: 26350399
[TBL] [Abstract][Full Text] [Related]
36. Myeloid TBK1 Deficiency Induces Motor Deficits and Axon Degeneration Through Inflammatory Cell Infiltration.
Duan W; Yi L; Tian Y; Huang HP; Li Z; Bi Y; Guo M; Li Y; Liu Y; Ma Y; Song X; Liu Y; Li C
Mol Neurobiol; 2021 May; 58(5):2435-2446. PubMed ID: 33439438
[TBL] [Abstract][Full Text] [Related]
37. Identifying actionable druggable targets for breast cancer: Mendelian randomization and population-based analyses.
Zhang N; Li Y; Sundquist J; Sundquist K; Ji J
EBioMedicine; 2023 Dec; 98():104859. PubMed ID: 38251461
[TBL] [Abstract][Full Text] [Related]
38. Work-related factors and risk of amyotrophic lateral sclerosis: A multivariable Mendelian randomization study.
Li M; Liao Y; Luo Z; Song H; Yang Z
Brain Behav; 2023 Dec; 13(12):e3317. PubMed ID: 37960974
[TBL] [Abstract][Full Text] [Related]
39. Serum Creatinine Protects Against Amyotrophic Lateral Sclerosis: a Mendelian Randomization Study.
Wang M; Liu D; Zhang Z; Xie W; Cao L; Zhu L; Liu M; Sheng S; Lian X
Mol Neurobiol; 2021 Jun; 58(6):2910-2915. PubMed ID: 33555548
[TBL] [Abstract][Full Text] [Related]
40. Summary-data-based Mendelian randomization prioritizes potential druggable targets for multiple sclerosis.
Jacobs BM; Taylor T; Awad A; Baker D; Giovanonni G; Noyce AJ; Dobson R
Brain Commun; 2020; 2(2):fcaa119. PubMed ID: 33005893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
